Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injury
- PMID: 25206871
- PMCID: PMC4146266
- DOI: 10.4103/1673-5374.131564
Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injury
Abstract
IN THE HOURS TO WEEKS FOLLOWING TRAUMATIC SPINAL CORD INJURIES (SCI), BIOCHEMICAL PROCESSES ARE INITIATED THAT FURTHER DAMAGE THE TISSUE WITHIN AND SURROUNDING THE INITIAL INJURY SITE: a process termed secondary injury. Acrolein, a highly reactive unsaturated aldehyde, has been shown to play a major role in the secondary injury by contributing significantly to both motor and sensory deficits. In particular, efforts have been made to elucidate the mechanisms of acrolein-mediated damage at the cellular level and the resulting paralysis and neuropathic pain. In this review, we will highlight the recent developments in the understanding of the mechanisms of acrolein in motor and sensory dysfunction in animal models of SCI. We will also discuss the therapeutic benefits of using acrolein scavengers to attenuate acrolein-mediated neuronal damage following SCI.
Keywords: 3-hydrxypropyl mercapturic acid; acrolein-lysine adduct; hydralazine; oxidative stress; spinal cord injury.
Figures
Similar articles
-
Mitigation of sensory and motor deficits by acrolein scavenger phenelzine in a rat model of spinal cord contusive injury.J Neurochem. 2016 Jul;138(2):328-38. doi: 10.1111/jnc.13639. Epub 2016 May 16. J Neurochem. 2016. PMID: 27060873 Free PMC article.
-
Neuroprotective role of hydralazine in rat spinal cord injury-attenuation of acrolein-mediated damage.J Neurochem. 2014 Apr;129(2):339-49. doi: 10.1111/jnc.12628. Epub 2013 Dec 15. J Neurochem. 2014. PMID: 24286176 Free PMC article.
-
Acrolein involvement in sensory and behavioral hypersensitivity following spinal cord injury in the rat.J Neurochem. 2014 Mar;128(5):776-786. doi: 10.1111/jnc.12500. Epub 2013 Nov 13. J Neurochem. 2014. PMID: 24147766 Free PMC article.
-
Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury.J Neurochem. 2009 Dec;111(6):1348-56. doi: 10.1111/j.1471-4159.2009.06395.x. Epub 2009 Sep 23. J Neurochem. 2009. PMID: 19780896 Review.
-
Acrolein detection: potential theranostic utility in multiple sclerosis and spinal cord injury.Expert Rev Neurother. 2014 Jun;14(6):679-85. doi: 10.1586/14737175.2014.918849. Epub 2014 May 16. Expert Rev Neurother. 2014. PMID: 24831349 Free PMC article. Review.
Cited by
-
Therapeutic Potential of Combinative shRNA-Encoded Lentivirus-Mediated Gene Silencing to Accelerate Somatosensory Recovery After Spinal Cord Trauma.Neurotherapeutics. 2023 Mar;20(2):564-577. doi: 10.1007/s13311-022-01331-7. Epub 2022 Nov 18. Neurotherapeutics. 2023. PMID: 36401079 Free PMC article.
-
Urinary acrolein metabolite levels in severe acute alcoholic hepatitis patients.Am J Physiol Gastrointest Liver Physiol. 2019 Jan 1;316(1):G115-G122. doi: 10.1152/ajpgi.00209.2018. Epub 2018 Sep 20. Am J Physiol Gastrointest Liver Physiol. 2019. PMID: 30234998 Free PMC article.
-
Systemic Acrolein Elevations in Mice With Experimental Autoimmune Encephalomyelitis and Patients With Multiple Sclerosis.Front Neurol. 2018 Jun 15;9:420. doi: 10.3389/fneur.2018.00420. eCollection 2018. Front Neurol. 2018. PMID: 29963001 Free PMC article.
-
Dimercaprol is an acrolein scavenger that mitigates acrolein-mediated PC-12 cells toxicity and reduces acrolein in rat following spinal cord injury.J Neurochem. 2017 Jun;141(5):708-720. doi: 10.1111/jnc.14025. Epub 2017 May 3. J Neurochem. 2017. PMID: 28301040 Free PMC article.
-
Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: involvement of α-synuclein aggregation and programmed cell death.Sci Rep. 2017 Apr 12;7:45741. doi: 10.1038/srep45741. Sci Rep. 2017. PMID: 28401906 Free PMC article.
References
-
- Adams JD, Jr, Klaidman LK. Acrolein-induced oxygen radical formation. Free Radic Biol Med. 1993;15:187–193. - PubMed
-
- Andrade EL, Meotti FC, Calixto JB. TRPA1 antagonists as potential analgesic drugs. Pharmacol Ther. 2012;133:189–204. - PubMed
-
- Azbill RD, Mu X, Bruce-Keller AJ, Mattson MP, Springer JE. Impaired mitochondrial function oxidative stress and altered, antioxidant enzyme activities following traumatic spinal cord injury. Brain Res. 1997;765:283–290. - PubMed
-
- Basso DM, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol. 1996;139:244–256. - PubMed
-
- Borgens RB, Liu-Snyder P. Understanding secondary injury. Q Rev Biol. 2012;87:89–127. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources